Review article: consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases

Overview of attention for article published in Alimentary Pharmacology & Therapeutics, October 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source
twitter: 43 X users
patent: 1 patent

facebook: 1 Facebook page
reddit: 1 Redditor
guideline: 2 clinical guideline sources

Readers on

mendeley: 257 Mendeley

So far, Altmetric has seen 48 X posts from 43 X users, with an upper bound of 90,926 followers.

@IBDMD @AetnaHelp Here is more data and consensus on therapeutic drug monitoring for #IBD in Australia.

RT @jenhelenmar: Great to have consistent data to back up the work from the combined ANZIBD and ASCEPT group in 2017, particularly for this…

Great to have consistent data to back up the work from the combined ANZIBD and ASCEPT group in 2017, particularly for this IBD population. Role for routine TDM? https://t.co/XXtXqze2lv @ASCEPTanz @stevenbollipo @IATDMCT

RT @FarmaCHUAC: 📚 Consenso #MonitorizaciónFarmacocinética anti-TNF en #EnfermedadInflamatoriaIntestinal para optimización tratamiento https…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 44 additional X posts.